Objectives Candida glabrata is one of the most common causes of Candida bloodstream infections worldwide. Some isolates of C glabrata may be intermediately resistant to azoles, with some strains developing resistance during therapy or prophylaxis with fluconazole. In this study, we used a proteomic approach to identify differentially expressed proteins between fluconazoleresistant and -susceptible strains. Methods
Membrane and cellular proteins were extracted from fluconazolesusceptible and fluconazole-resistant C glabrata strains. Differentially expressed proteins were compared using two-dimensional sodium dodecyl sulfate polyacrylamide gel electrophoresis. Proteins with >1.5-fold difference in expression were identified by liquid chromatography tandem mass spectrometry (LC-MS/MS). Results
A total of 65 proteins were differentially expressed in the cellular and membrane fractions. Among the 39 cellular proteins, 11 were upregulated and 28 were downregulated in fluconazole-resistant strains in comparison with fluconazole-susceptible strains. In the membrane fraction, a total of 26 proteins were found, of which 19 were upregulated and seven were downregulated. A total of 31 proteins were identified by LC-MS/MS that are involved in glycolysis, carbohydrate transport, energy transfer, and other metabolic pathways. Heat shock proteins were identified in various spots. Conclusion
Heat shock and stress response proteins were upregulated in the membrane fraction of the fluconazole-resistant C glabrata strain. Compared with susceptible strains, fluconazole-resistant strains showed increased expression of membrane proteins and decreased expression of cellular proteins.
Citations
Citations to this article as recorded by
What ‘Omics can tell us about antifungal adaptation Gabriela Fior Ribeiro, Eszter Denes, Helen Heaney, Delma S Childers FEMS Yeast Research.2022;[Epub] CrossRef
Effects of antifungal agents on the fungal proteome: informing on mechanisms of sensitivity and resistance Rebecca A. Owens, Sean Doyle Expert Review of Proteomics.2021; 18(3): 185. CrossRef
HPLC-MS identification and expression of Candida drug-resistance proteins from African HIV-infected patients Pedro M D S Abrantes, Randall Fisher, Patrick J D Bouic, Carole P McArthur, Burtram C Fielding, Charlene W J Africa AIMS Microbiology.2021; 7(3): 320. CrossRef
Transcriptional responses of Candida glabrata biofilm cells to fluconazole are modulated by the carbon source Rosana Alves, Stavroula L. Kastora, Alexandra Gomes-Gonçalves, Nuno Azevedo, Célia F. Rodrigues, Sónia Silva, Liesbeth Demuyser, Patrick Van Dijck, Margarida Casal, Alistair J. P. Brown, Mariana Henriques, Sandra Paiva npj Biofilms and Microbiomes.2020;[Epub] CrossRef
Proteomics Analysis of Candida albicans dnm1 Haploid Mutant Unraveled the Association between Mitochondrial Fission and Antifungal Susceptibility Thuyen Truong, Guisheng Zeng, Teck Kwang Lim, Tong Cao, Li Mei Pang, Yew Mun Lee, Qingsong Lin, Yue Wang, Chaminda Jayampath Seneviratne PROTEOMICS.2020;[Epub] CrossRef
Membrane Proteome-Wide Response to the Antifungal Drug Clotrimazole in Candida glabrata: Role of the Transcription Factor CgPdr1 and the Drug:H+ Antiporters CgTpo1_1 and CgTpo1_2 Pedro Pais, Catarina Costa, Carla Pires, Kiminori Shimizu, Hiroji Chibana, Miguel C. Teixeira Molecular & Cellular Proteomics.2016; 15(1): 57. CrossRef